Tradestie Institutional Equity Comparison Engine

DNA vs STEM โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

DNA Overall Edge

DNA Captures Institutional Edge (2โ€“1 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ginkgo Bioworks Holdings, Inc. (DNA) driven by superior Momentum & Technical, Options & Structure while STEM counters with relative strength in Growth & Margin. Fundamentally, DNA trades at N/M Forward P/E with -202.5% operating margin (-5.7% YoY revenue) versus STEM at N/M Forward P/E and -12.1% operating margin (-4.1% YoY). In options structure, DNA sits in BREAKDOWN (22nd %ile IV; Dealer Gamma Walls on Pro) against STEM sits in BREAKDOWN (39th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
DNA N/M vs STEM N/M Fwd P/E
Growth & Margin Winner STEM
Op Margin -202.5% vs -12.1% ยท YoY -5.7% vs -4.1%
Momentum & Technical Winner DNA
1Y -5.7% vs -95.8% ยท 52W Pos 16% vs 0%
Options & Structure Winner DNA
BREAKDOWN (22nd %ile IV) vs BREAKDOWN (39th %ile IV)
DNA NYSE
Ginkgo Bioworks Holdings, Inc.
Biological Products, (No Disgnostic Substances)
$7.46
-9.02% 1D
Market Cap $531.5M
1M Return -23.17%
1Y Return -5.69%
Forward P/E N/M
Unified AI Score
52.1 / 100 HOLD
Tech 45.0 Fund 56.0 Flow 68.0 Mom 60.0
STEM NYSE
Stem, Inc.
Miscellaneous Electrical Machinery, Equipment & Supplies
$0.64
-12.73% 1D
Market Cap $7.1M
1M Return -78.77%
1Y Return -95.84%
Forward P/E N/M
Unified AI Score
42.4 / 100 HOLD
Tech 25.0 Fund 46.0 Flow 61.0 Mom 59.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: DNA -5.69% STEM -95.84% Spread: +90.15 pp (DNA Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period DNA Revenue STEM Revenue DNA Op. Margin STEM Op. Margin Margin Edge
FY2019 $50M $20M -132.1% -272.6% DNA
FY2020 $80M $40M -178.8% -136.0% STEM
FY2021 $310M $130M -582.6% -65.2% STEM
FY2022 $480M $360M -462.4% -36.1% STEM
FY2023 $250M $460M -343.8% -38.9% STEM
FY2024 $230M $140M -246.5% -580.6% DNA
FY2025 $170M $160M -185.3% -35.6% STEM

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: DNA (5) vs STEM (3)
Institutional Metric DNA STEM Criterion Row Winner
Market Capitalization Scale $531.5M $7.1M Larger Scale DNA
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -5.7% -4.1% Higher Growth STEM
Operating Margin (TTM) Profitability -202.5% -12.1% Higher Margin STEM
Net Profit Margin Profitability -192.0% -43.6% Higher Margin STEM
Return on Equity (ROE) Capital Efficiency -58.2% -5920.8% Higher ROE DNA
52-Week Range Position Momentum 16% ($5โ€“$18) 0% ($1โ€“$22) Stronger Trend DNA
Beta / 30D Volatility Risk Regime 3.12ฮฒ ยท 152% Vol 4.60ฮฒ ยท 234% Vol Lower Realized Risk DNA
Unified Institutional Score Composite Signal 52.1 / 100 (HOLD) 42.4 / 100 (HOLD) Higher Composite DNA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full DNA vs STEM Buy Guide
DNA BREAKDOWN
34d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 22nd %ile
IV Regime Compressed (<25th %ile)
Live DNA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
STEM BREAKDOWN
145d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 39th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live STEM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither DNA nor STEM registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.